Kaustubh Datta, PhD

Associate Professor, Biochemistry & Molecular Biology
Courtesy Associate Professor, Pathology & Microbiology
Courtesy Associate Professor, Eppley Institute for Cancer Research
Member, Fred & Pamela Buffett Cancer Center

Phone402-559-7404

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Kaustubh Datta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
2 Finished

Nuclear Neuropilin2: a novel molecular mediator for aggressive Prostate Cancer
Datta, K.
Project: Research project
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
Datta, K.
National Institutes of Health
2/1/15 → 1/31/20
Project: Research project
The role of VEGF-C in resisting stress in prostate cancer
Datta, K.
National Institutes of Health
2/1/10 → 1/31/16
Project: Research project

2086 Citations
26 h-Index
46 Article
6 Review article
3 Chapter
1 Comment/debate

Sildenafil potentiates the therapeutic efficacy of docetaxel in advanced prostate cancer by stimulating NO-cGMP signaling
Muniyan, S., Rachagani, S., Parte, S., Halder, S., Seshacharyulu, P., Kshirsagar, P., Siddiqui, J. A., Vengoji, R., Rauth, S., Islam, R., Mallya, K., Datta, K., Xi, L., Das, A., Teply, B. A., Kukreja, R. C. & Batra, S. K., Nov 1 2021, In: Clinical Cancer Research. 26, 21, p. 5720-5734 15 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients
Muniyan, S., Xi, L., Datta, K., Das, A., Teply, B. A., Batra, S. K. & Kukreja, R. C., Aug 2020, In: Biochimica et Biophysica Acta - Reviews on Cancer. 1874, 1, 188383.
Research output: Contribution to journal › Review article › peer-review
4 Scopus citations
Elevating SOX2 in prostate tumor cells upregulates expression of neuroendocrine genes, but does not reduce the inhibitory effects of enzalutamide
Metz, E. P., Wilder, P. J., Dong, J., Datta, K. & Rizzino, A., Apr 1 2020, In: Journal of Cellular Physiology. 235, 4, p. 3731-3740 10 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer
Schulz, A., Gorodetska, I., Behrendt, R., Fuessel, S., Erdmann, K., Foerster, S., Datta, K., Mayr, T., Dubrovska, A. & Muders, M. H., Jan 21 2020, In: Frontiers in Oncology. 9, 1461.
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations
Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate
Borkowetz, A., Froehner, M., Rauner, M., Conrad, S., Erdmann, K., Mayr, T., Datta, K., Hofbauer, L. C., Baretton, G. B., Wirth, M., Fuessel, S., Toma, M. & Muders, M. H., May 1 2020, In: International Journal of Cancer. 146, 9, p. 2619-2627 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations